Michael Burgess actually said...
I was concerned about some of the restrictions that this committee placed on the advisory panels that advise the FDA about the approval or non-approval of drugs and devices.
Context
Burgess expresses concern over restrictions on FDA advisory panels affecting drug approvals.
07/06/2011